サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1376389

人工心肺自動輸血システム市場：製品、用途、エンドユーザー別-2023-2030年の世界予測

Cardiopulmonary Autotransfusion Systems Market by Product (Off-Pump Transfusion Device, On-Pump Transfusion Device), Application (Cardiac Surgery, Organ Transplant, Orthopedic Surgery), End User - Global Forecast 2023-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 189 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
人工心肺自動輸血システム市場：製品、用途、エンドユーザー別-2023-2030年の世界予測
出版日: 2023年10月16日
発行: 360iResearch
ページ情報: 英文 189 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

人工心肺自動輸血システム市場は、2022年の5億5,236万米ドルから2030年には6億8,931万米ドルに達すると予測され、予測期間中のCAGRは2.80%です。

人工心肺自動輸血システムの世界市場

主な市場の統計
市場金額：基準年[2022] 5億5,236万米ドル
推定市場金額[2023] 5億6,662万米ドル
予測市場金額[2030]USD 689.31 million 6億8,931万米ドル
CAGR（%） 2.80%
人工心肺自動輸血システム Market-IMG1

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは人工心肺自動輸血システム市場の評価に不可欠なツールです。事業戦略や製品満足度に関連する主要指標を分析し、ベンダーを包括的に評価します。これにより、ユーザーは特定のニーズに合わせた情報に基づいた意思決定を行うことができます。高度な分析により、ベンダーは4つの象限に分類され、それぞれ成功のレベルが異なります：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。この洞察に満ちたフレームワークにより、意思決定者は自信を持って市場をナビゲートすることができます。

市場シェア分析

市場シェア分析では、ベンダーの市場情勢に関する貴重な洞察を提供します。全体収益、顧客ベース、その他の主要指標への影響を評価することで、企業の業績と直面する競合環境を包括的に理解することができます。この分析では、調査期間中の市場シェア獲得、断片化、優位性、業界再編などの競合レベルも明らかにします。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業の市場力学と製品に関する包括的な情報を提供します。

2.市場の開拓度：新興市場と成熟市場セグメントへの浸透度を詳細に分析し、有利なビジネスチャンスを浮き彫りにします。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細情報。

4.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関するインテリジェントな洞察。

本レポートは、以下のような主要な質問に対応しています：

1.人工心肺自動輸血システム市場の市場規模および予測は？

2.人工心肺自動輸血システム市場で最も高い投資ポテンシャルを持つ製品、セグメント、用途、分野は？

3.人工心肺自動輸血システム市場における競争戦略の窓とは？

4.人工心肺自動輸血システム市場の最新技術動向と規制の枠組みは？

5.人工心肺自動輸血システム市場における主要ベンダーの市場シェアは？

6.人工心肺自動輸血システム市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 高齢化の進展と心臓手術件数の増加
      • ヘルスケア費の増加と外科手術の進歩
      • 血液保存に対する需要の高まり
    • 抑制要因
      • システムのコストが高く、運用が複雑
    • 機会
      • 人工心肺自動輸血システムの技術の進歩
      • 血液処理技術の革新と高度な濾過システム
    • 課題
      • 感染リスクと汚染問題に関連する懸念
  • 市場セグメンテーション分析
  • 市場動向分析
  • 高インフレの累積的影響
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 規制の枠組み

第6章 人工心肺自動輸血システム市場：製品別

  • オフポンプ輸血装置
  • オンポンプ輸血装置

第7章 人工心肺自動輸血システム市場：用途別

  • 心臓手術
  • 臓器移植
  • 整形外科
  • 外傷の処置

第8章 人工心肺自動輸血システム市場：エンドユーザー別

  • 外来手術センター
  • 心臓研究センター
  • 病院

第9章 南北アメリカの人工心肺自動輸血システム市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の人工心肺自動輸血システム市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの人工心肺自動輸血システム市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリクス
  • 市場シェア分析：主要企業別
  • 競合シナリオ分析：主要企業別

第13章 競争力のあるポートフォリオ

  • 主要企業プロファイル
    • Advancis Surgical
    • Becton, Dickinson and Company
    • Beijing ZKSK Technology Co., Ltd.
    • Braile Biomedica
    • Brightwake Ltd.
    • Fresenius Kabi
    • Getinge AB
    • Global Blood Resources, LLC
    • LivaNova International
    • Medtronic PLC
    • ProCell Surgical
    • SARSTEDT
    • Stryker Corporation
    • Teleflex Incorporated
    • Terumo Interventional Systems
    • Zimmer Biomet Holdings, Inc.
  • 主要な製品ポートフォリオ

第14章 付録

  • ディスカッションガイド
  • ライセンスと価格について
図表

LIST OF FIGURES

  • FIGURE 1. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET RESEARCH PROCESS
  • FIGURE 2. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET DYNAMICS
  • FIGURE 7. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
  • FIGURE 8. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
  • FIGURE 10. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2022 VS 2030 (%)
  • FIGURE 12. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 14. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 16. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 22. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 6. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY OFF-PUMP TRANSFUSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY ON-PUMP TRANSFUSION DEVICE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY ORGAN TRANSPLANT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY ORTHOPEDIC SURGERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY TRAUMA PROCEDURES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 14. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY CARDIAC RESEARCH CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 144. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 145. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 146. CARDIOPULMONARY AUTOTRANSFUSION SYSTEMS MARKET LICENSE & PRICING
目次
Product Code: MRR-69324464D33E

The Cardiopulmonary Autotransfusion Systems Market is projected to reach USD 689.31 million by 2030 from USD 552.36 million in 2022, at a CAGR of 2.80% during the forecast period.

Global Cardiopulmonary Autotransfusion Systems Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 552.36 million
Estimated Year Value [2023] USD 566.62 million
Forecast Year Value [2030] USD 689.31 million
CAGR (%) 2.80%
Cardiopulmonary Autotransfusion Systems Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Cardiopulmonary Autotransfusion Systems Market.

Based on Product, market is studied across Off-Pump Transfusion Device and On-Pump Transfusion Device. The Off-Pump Transfusion Device is projected to witness significant market share during forecast period.

Based on Application, market is studied across Cardiac Surgery, Organ Transplant, Orthopedic Surgery, and Trauma Procedures. The Orthopedic Surgery is projected to witness significant market share during forecast period.

Based on End User, market is studied across Ambulatory Surgical Centers, Cardiac Research Centers, and Hospitals. The Ambulatory Surgical Centers is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Cardiopulmonary Autotransfusion Systems Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Cardiopulmonary Autotransfusion Systems Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Cardiopulmonary Autotransfusion Systems Market, highlighting leading vendors and their innovative profiles. These include Advancis Surgical, Becton, Dickinson and Company, Beijing ZKSK Technology Co., Ltd., Braile Biomedica, Brightwake Ltd., Fresenius Kabi, Getinge AB, Global Blood Resources, LLC, LivaNova International, Medtronic PLC, ProCell Surgical, SARSTEDT, Stryker Corporation, Teleflex Incorporated, Terumo Interventional Systems, and Zimmer Biomet Holdings, Inc..

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Cardiopulmonary Autotransfusion Systems Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Cardiopulmonary Autotransfusion Systems Market?

3. What is the competitive strategic window for identifying opportunities in the Cardiopulmonary Autotransfusion Systems Market?

4. What are the latest technology trends and regulatory frameworks in the Cardiopulmonary Autotransfusion Systems Market?

5. What is the market share of the leading vendors in the Cardiopulmonary Autotransfusion Systems Market?

6. Which modes and strategic moves are suitable for entering the Cardiopulmonary Autotransfusion Systems Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cardiopulmonary Autotransfusion Systems Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing aging population and increase in number of cardiac surgeries
      • 5.1.1.2. Rising healthcare expenditure and advancements in surgical procedures
      • 5.1.1.3. Increasing demand for blood conservation
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of the system and operational complexity
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in the cardiopulmonary autotransfusion systems
      • 5.1.3.2. Innovations in the blood processing techniques and advanced filtration systems
    • 5.1.4. Challenges
      • 5.1.4.1. Concerns associated with infection risks and contamination issues
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Cardiopulmonary Autotransfusion Systems Market, by Product

  • 6.1. Introduction
  • 6.2. Off-Pump Transfusion Device
  • 6.3. On-Pump Transfusion Device

7. Cardiopulmonary Autotransfusion Systems Market, by Application

  • 7.1. Introduction
  • 7.2. Cardiac Surgery
  • 7.3. Organ Transplant
  • 7.4. Orthopedic Surgery
  • 7.5. Trauma Procedures

8. Cardiopulmonary Autotransfusion Systems Market, by End User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgical Centers
  • 8.3. Cardiac Research Centers
  • 8.4. Hospitals

9. Americas Cardiopulmonary Autotransfusion Systems Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Cardiopulmonary Autotransfusion Systems Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Cardiopulmonary Autotransfusion Systems Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Advancis Surgical
    • 13.1.2. Becton, Dickinson and Company
    • 13.1.3. Beijing ZKSK Technology Co., Ltd.
    • 13.1.4. Braile Biomedica
    • 13.1.5. Brightwake Ltd.
    • 13.1.6. Fresenius Kabi
    • 13.1.7. Getinge AB
    • 13.1.8. Global Blood Resources, LLC
    • 13.1.9. LivaNova International
    • 13.1.10. Medtronic PLC
    • 13.1.11. ProCell Surgical
    • 13.1.12. SARSTEDT
    • 13.1.13. Stryker Corporation
    • 13.1.14. Teleflex Incorporated
    • 13.1.15. Terumo Interventional Systems
    • 13.1.16. Zimmer Biomet Holdings, Inc.
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing